Belén Garijo is a Spanish business executive. Since May 2021, she has been the CEO and chair of the executive board of Merck Group. From Wikipedia
The acquisition boosts Merck’s oncology pipeline with rare-tumor treatments pending EU approval for Springworks’ therapies.
